Microfilament depletion and circumvention of multiple drug resistance by sphinxolides

Cancer Research

Volumn 57, Issue 17, 1997, Pages 3751-3758

  Zhang, Xinqun ^a   Minale, Luigi ^b   Zampella, Angela ^b   Smith, Charles D ^a  

^a FOX CHASE CANCER CENTER   (United States)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; CYTOCHALASIN; CYTOTOXIN; GLYCOPROTEIN P; SPHINXOLIDE DERIVATIVE; UNCLASSIFIED DRUG;

ACTIN POLYMERIZATION; APOPTOSIS; ARTICLE; CELL CYCLE; CELL CYCLE G2 PHASE; CELL PROLIFERATION; CYTOTOXICITY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MICROFILAMENT; MICROTUBULE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL;

ACTINS; ADENOSINE TRIPHOSPHATASES; ANIMALS; ANTINEOPLASTIC AGENTS; CELL CYCLE; CYTOCHALASIN B; CYTOTOXINS; DNA FRAGMENTATION; DNA TOPOISOMERASES, TYPE I; DNA TOPOISOMERASES, TYPE II; DRUG RESISTANCE, MULTIPLE; DRUG SCREENING ASSAYS, ANTITUMOR; HL-60 CELLS; HUMANS; MICROFILAMENTS; MUSCLE, SMOOTH, VASCULAR; POLYMERS; PORIFERA; PYRANS; TUMOR CELLS, CULTURED;

EID: 0030777109     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Rowinsky, E. K., and Donehower, R. C. The clinical pharmacology and use of antimicrotubule agents in cancer chemotherapeutics. Pharmacol. Ther., 52: 35-84, 1991.
2. Pratt, W. B., Ruddon, R. W., Ensminger, W. D., and Maybaum, J. Inhibitors of chromatin function. In: The Anlicancer Drugs, Ed. 2, pp. 183-198. New York: Oxford University Press, 1994.
3. Calabresi, P., Clark, J., Hanauske, A. R., and Wiemann, M. C. Pharmacology of antineoplastic agents. In: P. Calabresi and P. S. Schein (eds.), Medical Oncology, Ed. 2, pp. 263-321. New York: McGraw-Hill, 1993.
4. Farmer, S. R. Actin. A regulator of cell growth and differentiation. In: J. W. Shay (ed.), Cell and Molecular Biology of the Cytoskeleton, pp. 131-149. New York: Plenum Publishing Corp., 1986.
5. Janmey, P. A., and Chaponnier, C. Medical aspects of the actin cytoskeleton. Curr. Opin. Cell Biol., 7: 111-117, 1995.
6. Kunze, D., and Rustow, B. Pathobiochemical aspects of cytoskeletal components. Eur. J. Chem. Clin. Biochem., 31: 477-489, 1993.
7. Patterson, G. M. L., Smith, C. D., Kimura, L. H., Britten, B., and Carmeli, S. Action of tolytoxin on cell morphology and cytoskeletal structure in vitro. Cell Motil. Cytoskel., 24: 39-48, 1993.
8. Spector, I., Shochet, N. R., Blasberger, D., and Kashman, Y. Latrunculins: novel marine macrolides that disrupt microfilament organization and affect cell growth. I. Comparison with cytochalasin D. Cell Motil. Cytoskeleton, 13: 127-144, 1989.
9. Bubb, M. R., Spector, I., Bershadsky, A. D., and Korn, E. D. Swinholide A is a microfilament disrupting marine toxin that stabilizes actin dimers and severs actin filaments. J. Biol. Chem., 270: 3463-3466, 1995.
10. Senderowicz, A. M. J., Kaur, G., Sainz, E., Laing, C., Inman, W. D., Rodriguez, J., Crews, P., Malspeis, L., Grever, M. R., Sausville, E. A., and Duncan, K. L. K. Jasplakinolide's inhibition of the growth of prostate carcinoma cells in vitro with disruption of the actin cytoskeleton. J. Natl. Cancer Inst., 87: 46-51, 1995.
11. Saito, S., Watabe, S., Ozaki, Fusetani, N., and Karaki, H. Mycalolide B, a novel actin depolymerizing agent. J. Biol. Chem., 269: 29710-29714, 1994.
12. Endicott, J. A., and Ling, V. The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu. Rev. Biochem., 58: 137-171, 1989.
13. Gottesman, M. M., and Pastan, I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem., 62: 385-427, 1993.
14. Raderer, M., and Scheithauer, W. Clinical trials of agents that reverse multidrug resistance. A literature review. Cancer (Phila.), 72: 3553-3563, 1993.
15. Smith, C. D., Zhang, X., Mooberry, S. L., Patterson, G. M. L., and Moore, R. E. Cryptophycin: a new antimicrotubule agent active against drug-resistant cells. Cancer Res., 54: 3779-3785, 1994.
16. Smith, C. D., and Zhang, X. Mechanism of action of cryptophycin. J. Biol. Chem., 271: 6192-6198, 1996.
17. Smith, C. D., Carmeli, S., Moore, R. E., and Patterson, G. M. L. Scytophycins: novel microfilament-depolymerizing agents which circumvent P-glycoprotein mediated multidrug resistance. Cancer Res., 53: 1343-1347, 1993.
18. D'Auria, M. V., Paloma, L. G., Minale., L., and Zampella, A., Verbist, J. F., Roussakis, C., and Debitus, C. Three new potent cytotoxic macrolides closely related to sphinxolide from the New Caledonian sponge Neosiphonia superstes. Tetrahedron, 49: 8657-8664, 1993.
19. Guella, G., Manicini, I., Chiasera, G., and Pietra, F. Sphinxolide, a 26-membered antitumoral macrolide isolated from an unidentified Pacific nudibranch. Helv. Chim. Acta, 72: 237-246, 1989.
20. Fairchild, C. R., Ivy, S. P., Kao-Shan, C-S., Whang-Peng, J., Rosen, N., Isreal M. A., Melera, P. W., Cowan, K. H., and Goldsmith, M. E. Isolation of amplified and overexpressed DNA sequences from Adriamycin-resistant human breast cancer cells. Cancer Res., 47: 5141-5148, 1987.
21. Krishnamachary, N., and Center, M. S. The MRP gene associated with a non-P-glycoprotein multidrug resistance encodes a 190-kDa membrane-bound glycoprotein. Cancer Res., 53: 3658-3661, 1993.
22. Skehan, P., Stoneng, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D., Warren, J. T., Bokesch, H., Kenney, S., and Boyd, M. R. New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer Inst., 82: 1107-1112, 1990.
23. Smith, C. D., Prinsep, M. R., Caplan, F. R., Moore, R. E., and Patterson, G. M. L. Reversal of multiple drug resistance by tolyporphin, a novel cyanobacterial natural product. Oncol. Res., 6: 211-218, 1994.
24. Smith, C. D., Zilfou, J. T., Stratmann, K., Patterson, G. M. L., and Moore, R. E. Welwitindolinone analogues that reverse P-glycoprotein-mediated multiple drug resistance. Mol. Pharmacol., 47: 241-247, 1995.
25. Vindelov, L. L., Christensen, I. J., and Nissen, N. I. A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry, 3: 323-327, 1983.
26. Ruscha, M. F., and Himes, R. H. A simple procedure for the isolation of brain actin. Prep. Biochem., 11: 351-360, 1981.
27. Cooper, J. A. Effects of cytochalasin and phalloidin on actin. J. Cell Biol., 105: 1473-1478, 1987.
28. Smith, C. D., and Wells, W. W. Solubilization and reconstitution of a nuclearenvelope-associated ATPase. J. Biol. Chem., 259: 11890-11894, 1984.
29. van der Graaf, W. T. A., de Vries, E. G. E., Timmer-Bosscha, H., Meersma, G. J., Mesander, G., Vellenga, E., and Mulder, N. H. Effects of amiodarone, cyclosporin A, and PSC 833 on the cytotoxicity of mitoxanthrone, doxorubicin, and vincristine in non-P-glycoprotein human small cell lung cancer cell lines. Cancer Res., 54: 5368-5373, 1994.
30. Smith, C. D., Zilfou, J. T., Zhang, X., Hudes, G. R., and Tew, K. D. Modulation of P-glycoprotein activity by estramustine is limited by binding to plasma proteins. Cancer (Phila.), 75: 2597-2604, 1995.
31. Zilfou, J. T., and Smith, C. D. Differential interactions of cytochalasins with P-glycoprotein. Oncol. Res., 7: 435-443, 1995.
32. Patterson, G. M. L., Smith, C. D., Kimura, L. H., Britton, B. A., and Carmeli, S. Action of tolytoxin on cell morphology, cytoskeletal organization, and actin polymerization. Cell Motil. Cyloskel., 24: 39-48, 1993.
33. Saito, S., Watabe, S., Ozaki, H., Fusetani, N., Yamada, K., and Karaki, H. Novel inhibitors of actin polymerization, bistheonellide A and aplyronine A: comparison with mycalolide B. Jpn. J. Pharmacol., 67 (Suppl. 1): 205, 1995.
34. 32 subunit of scytophycin C. Tetrahedron Lett., 34: 5347-5350, 1993.
35. Paterson, I., Watson, C., Yeung, K-S., Wallace, P. A., and Ward, R. A. Total synthesis of scytophycin C. J. Org. Chem., 62: 452-453, 1997.
36. Bousquet, P. F., Paulsen, L. A., Fondy, C., Lipski, K. M., Loucy, K. J., and Fondy, T. P. Effects of cytochalasin B in culture and in vivo on mouse Madison 109 lung carcinoma and on B16 melanoma. Cancer Res., 50: 1431-1439, 1990.